Physician profile
Muhammad Aamir
NPI 1477039147
$1,557.39
in general payments reported to CMS, 2019-2025
12 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $229 · 2023: $931 · 2024: $165 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $788 · Food and Beverage: $446 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $787.80 |
| Food and Beverage | $446.06 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,019.88 | 2022-2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $143.40 | 2022-2023 | Lifevest |
| Madrigal Pharmaceuticals | $79.17 | 2025 | Rezdiffra |
| Amgen INC. | $79.00 | 2025 | Repatha |
| Ge Healthcare | $60.76 | 2025 | |
| Esperion Therapeutics, INC. | $57.72 | 2022 | |
| Boston Scientific Corporation | $30.41 | 2022 | |
| Irhythm Technologies, INC. | $21.86 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.66 | 2023 | |
| Celgene Corporation | $17.17 | 2022 | |
| Inspire Medical Systems, INC. | $14.48 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals Lp | $12.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Aamir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.